A plus AVD for Treatment of Hodgkin Lymphoma Variant of Richter's Transformation

被引：0

作者：

Heyman, Benjamin ^{[1
]}

Choi, Michael ^{[2
]}

Kipps, Thomas J. ^{[3
]}

机构：

[1] UC San Diego Moores Canc Ctr, Dept Med, Div Regenerat Med, UC San Diego, La Jolla, CA 92093 USA

[2] Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

[3] Ctr Novel Therapeut, Dept Med, Div Hematol Oncol, UC San Diego, La Jolla, CA 92093 USA

来源：

CASE REPORTS IN HEMATOLOGY | 2024年 / 2024卷

关键词：

CHRONIC LYMPHOCYTIC-LEUKEMIA; BRENTUXIMAB VEDOTIN; PHASE-II; CHEMOTHERAPY; VENETOCLAX; OUTCOMES; THERAPY; DISEASE; ABVD; MOPP;

D O I：

10.1155/2024/7612622

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hodgkin lymphoma variant of Richter's transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the combination of brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A + AVD). In our series of 4 patients, two patients treated with A + AVD for HvRT had durable remissions of 40 and 42 months, while two patients had disease progression and ultimately died. Continued investigation into the optimal management for patients with HvRT is still needed.

引用

页数：8

共 50 条

[21] Hodgkin's Lymphoma: Richter's Transformation of Chronic Lymphocytic Leukemia Involving the Liver
Reddy, Nishitha
Thompson-Arildsen, Mary Ann
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : E543 - E544
[22] Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy
Taneja, Alankrita
Jones, Jade
Pittaluga, Stefania
Maric, Irina
Farooqui, Mohammed
Ahn, Inhye E.
Wiestner, Adrian
Sun, Clare
LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 519 - 522
[23] Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia
Zhu, Kai
Jamroz, Andrew
Huang, Steven
Villa, Diego
Freeman, Ciara L.
Scott, David W.
Slack, Graham
Sehn, Laurie H.
Connors, Joseph M.
Toze, Cynthia L.
Savage, Kerry J.
Gerrie, Alina S.
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : 684 - 692
[24] EARLY UNFAVORABLE CLASSIC HODGKIN LYMPHOMA TREATED WITH A plus AVD IN A PEDIATRIC PATIENT
Odetola, Olayinka
McCall, David
Gibson, Amber
Nunez, Cesar
Cuglievan, Branko
Garcia, Miriam
Roth, Micheal
PEDIATRIC BLOOD & CANCER, 2023, 70 : S78 - S79
[25] Mutational status of chronic lymphocytic leukemia (CLL) determines clonlal evolution in classical Hodgkin's lymphoma variant of Richter's transformation.
Chen, WW
Raffeld, M
Pittaluga, S
Sorbara, L
Jaffe, ES
BLOOD, 2005, 106 (11) : 596A - 596A
[26] POOR PROGNOSIS OF HODGKIN VARIANT OF RICHTER'S TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH CLADRIBINE
Jamroziak, K.
Grzybowska-Izydorczyk, O.
Jesionek-Kupnicka, D.
Gora-Tybor, J.
Robak, T.
HAEMATOLOGICA, 2012, 97 : 64 - 64
[27] Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature
Afonso, Carolina
Gomes, Marilia
Pereira, Marta Isabel
Faria, Carlos
Pina, Raquel
Saraiva, Tiago
Geraldes, Catarina
Carda, Jose Pedro
CLINICAL CASE REPORTS, 2022, 10 (10):
[28] Posttransplant Classic Hodgkin Lymphoma: Richter Transformation or Posttransplant Lymphoproliferative Disorder?
Lee, Ina
Zou, Ying
Hodges, Susan
Rapoport, Aaron P.
Hardy, Nancy
Singh, Zeba
AJSP-REVIEWS AND REPORTS, 2019, 24 (05): : 212 - 217
[29] Fine-needle aspiration biopsy findings in patients with presumed Hodgkin's variant of Richter's transformation
Reading, Fumiko
Stewart, John
Schlette, Ellen
Katz, Ruth
Caraway, Nancy
CANCER CYTOPATHOLOGY, 2006, 108 (05): : 417 - 418
[30] Richter's transformation in CLL—a distinct lymphoma
Preetesh Jain
Ken H. Young
Nature Reviews Clinical Oncology, 2014, 11 : 6 - 8

← 1 2 3 4 5 →